InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（3 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Barnes Alane P, Directeur Juridique. Officer active across 1 company, notably Biocryst Pharmaceuticals INC. In total, 22 reports have been logged. Split: 1 buy · 3 sells. Total volume traded: €719k. Activity tracked since 11 May 2021. The latest transaction was disclosed on 13 May 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Barnes Alane P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
62,500 股@ US$9.540.031% mcap46.2% 占其流量Common StockSEC:0000882796-26-000021:1
62,500 股@ US$5.040.016% mcap48.8% 占其流量Common StockSEC:0000882796-26-000021:0
150,000 股@ US$5.5137.7% 占其流量Common StockSEC:0000882796-26-000015:0
16,902 股@ US$7.417.3% 占其流量Common StockSEC:0000882796-25-000043:0
21,773 股@ US$7.659.7% 占其流量Common StockSEC:0000882796-25-000043:1
121,700 股0Common StockSEC:0001171843-25-008037:0
8,540 股@ US$7.572.5% 占其流量Common StockSEC:0000882796-25-000033:0
91,004 股@ US$3.2211.6% 占其流量Common StockSEC:0000882796-25-000027:0
2,461 股@ US$7.391.2% 占其流量Common StockSEC:0001127602-24-029952:1
120,700 股0Common StockSEC:0001127602-24-029952:0
8,613 股@ US$7.534.2% 占其流量Common StockSEC:0001127602-24-029582:0
5,000 股@ US$5.531.7% 占其流量Common StockSEC:0001127602-24-015367:0
标准退出：2024年8月11日 (T+90)
2,482 股@ US$6.050.9% 占其流量Common StockSEC:0001127602-23-030177:0
64,000 股0Common StockSEC:0001127602-23-029829:0
34,000 股0Common StockSEC:0001127602-22-028084:0
4,175 股@ US$10.882.9% 占其流量Common StockSEC:0001127602-22-027858:0
55,000 股0Common StockSEC:0001127602-22-001452:0
75,000 股0Common StockSEC:0001127602-21-031126:0
1,648 股@ US$4.730.3% 占其流量Common StockSEC:0001127602-21-016587:0
19,368 股Common StockSEC:0001127602-16-038681:0
2,599 股Common StockSEC:0001127602-16-037580:0
1,281 股Common StockSEC:0001127602-16-035665:0
22 条申报中的 22 条
About Barnes Alane P
Barnes Alane P is Chief Legal Officer at Biocryst Pharmaceuticals INC (XNAS). The declarant has 22 filings in total. Across the 22 sampled filings, buys amount to EUR 25617 and sells to EUR 693727, over the period from 2016-01-05 to 2026-05-15. The most frequent transaction nature is tax withholding.
